S100A9 and breast cancer: A few recent studies have reported that women with breast cancer who experience greater distress (76) or have lower social support and social wellbeing (SWB) (77) displayed greater inflammatory signaling and poorer clinical outcomes as well as greater S100A9/S100A9 levels (77).